Investor News: Depomed Inc (NASDAQ:DEPO) under Investigation

An investigation was announced for investors in NASDAQ:DEPO shares over potential breaches of fiduciary duties by certain Depomed directors.

Investors in Depomed Inc (NASDAQ:DEPO) shares should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858) 779 – 1554.

The investigation by a law firm for investors in NASDAQ:DEPO stocks follows a lawsuit filed recently against Depomed Inc over alleged securities laws violations. The investigation on behalf of current long term investors in NASDAQ:DEPO stocks, concerns whether certain Depomed directors are liable in connection with the allegations made in that lawsuit. The plaintiff alleges that the Defendants made false and/or misleading statements and/or failed to disclose that Depomed engaged in questionable practices in connection with the sales and marketing of the Company’s opioid products, that the foregoing conduct, when it became known, would likely subject the Company to heightened legal and regulatory scrutiny, and that as a result, Depomed’s public statements were materially false and misleading at all relevant times.

Those who purchased shares of Depomed Inc (NASDAQ:DEPO) have certain options and should contact the Shareholders Foundation.

Contact:
Shareholders Foundation, Inc.
Michael Daniels
3111 Camino Del Rio North – Suite 423
92108 San Diego
Phone: +1-(858)-779-1554
Fax: +1-(858)-605-5739
mail@shareholdersfoundation.com